close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RPRX

Recent news which mentions RPRX

< Previous 1 2 3 4 Next >
Royalty Pharma plc (RPRX) Q2 2022 Earnings Call Transcript
Tickers RPRX
Tags RPRX Market News Recent Press Releases
From Motley Fool
Royalty Pharma: Q2 Earnings Insights
Tickers RPRX
Tags News Market News BZI/Recaps
From Benzinga
3 Things Most Investors Don't Know About Warren Buffett's Investing Style
Tickers AAPL DVA JNJ LLY
Tags LLY Market News MCK
From Motley Fool
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Tickers AMYT BGNE BLU CFRX
Tags General Market News Health Care
From Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Tickers GSK INVA RPRX TBPH
Tags RPRX Briefs why it's moving
From Benzinga
This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'
Tickers BPMC RPRX
Tags Biotech Benzinga News
From Benzinga
Ipsen to acquire U.S.-based Epizyme for $247 million.
Tickers EPZM RPRX
Tags EPZM FR:IPN RPRX
From MarketWatch
5 Stocks Warren Buffett Has Aggressively Sold Since 2022 Began
Tickers ABBV BMY BRK-A BRK-B
Tags BMY BRK/B BRK/A
From Motley Fool
Expert Ratings for Royalty Pharma
Tickers RPRX
Tags Market News Benzinga BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Tickers AERC AINC BBY BGS
Tags TSCO Upgrades BWB
From Benzinga
Management of Technology Companies Continue Selling - Zillow (Z)
Tickers ANET BODY CAR CB
Tags NMRK NILE L
From Benzinga
Royalty Pharma Earnings Perspective: Return On Capital Employed
Tickers RPRX
Tags BZI/ROCE RPRX Market News
From Benzinga
Executives Sell Around $325M Of 3 Stocks
Tickers KD PBF RPRX
Tags Insider Selling RPRX Markets
From Benzinga
Here's Every Stock Warren Buffett Bought or Sold in the First Quarter
Tickers AAPL ALLY ATVI BRK-A
Tags MCK KR Market News
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
Tickers ATO AVYA BBI BUR
Tags SWCH BUR NEWR
From Benzinga
Expert Ratings for Royalty Pharma
Tickers RPRX
Tags Analyst Ratings RPRX BZI/AAR
From Benzinga
Royalty Pharma plc (RPRX) Q1 2022 Earnings Call Transcript
Tickers RPRX
Tags Recent Press Releases Market News RPRX
From Motley Fool
Royalty Pharma: Q1 Earnings Insights
Tickers RPRX
Tags Benzinga Earnings RPRX
From Benzinga
Recap: Royalty Pharma Q1 Earnings
Tickers RPRX
Tags RPRX Benzinga Earnings
From Benzinga
How To Attend Royalty Pharma Q1 2022 Earnings Conference Call
Tickers RPRX
Tags News BZI/CONF RPRX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
Tickers ADYEY AEVA AMH APLS
Tags SIEN RCM CMBM
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Tickers ABMD AMP APTV ARRY
Tags AY LEA NWE
From Benzinga
Expedia And 3 Other Stocks Insiders Are Selling
Tickers EXPE RPRX WM ZI
Tags WM EXPE Benzinga
From Benzinga
Hopeful Golden Cross Forms On Royalty Pharma's Chart
Tickers RPRX
Tags Benzinga RPRX Markets
From Benzinga
Looking Into Royalty Pharma's Return On Capital Employed
Tickers RPRX
Tags BZI/ROCE RPRX Earnings
From Benzinga
Royalty Pharma plc (RPRX) Q4 2021 Earnings Call Transcript
Tickers RPRX
Tags RPRX Recent Press Releases Market News
From Motley Fool
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
Tickers ADPT ATRC ATXI AYTU
Tags CERE ZEAL News
From Benzinga
Earnings Scheduled For February 15, 2022
Tickers ABG ABNB ACCO ACRE
Tags ATOM NEXA ILPT
From Benzinga
ProKidney Turns To Palihapitiya-Backed SPAC To Go Public In $2.6B Deal
Tickers DNAC IPOS RPRX
Tags Market News Health Care General
From Benzinga
DNAC Stock Alert: Chamath Palihapitiya’s SPAC Preps for ProKidney Merger
Tickers DNAC IPOD IPOF RPRX
Tags IPOD DNAC Market News
From InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today